Approval · Notice of Compliance 21903 · 2019
BYETTA: Notice of Compliance 21903
Issued February 28, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21903
- Date
- February 28, 2019
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a supplier and testing site
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BYETTA | Not yet assigned | — |
Medicinal ingredients
- EXENATIDE 250 MCG per ML